Active	Status	Sponsor type	Region	Phase	Filter
4 Active 5 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wheless, James W
NCT05067634 / 2020-005344-27: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures	Recruiting	3	140	Europe, US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	05/26	07/26
ARGUS, NCT04462770: A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome	Recruiting	2	100	Europe, Canada, US, RoW	EPX-100 (clemizole HCl), Placebo	Epygenix, Harmony Biosciences, LLC	Dravet Syndrome	04/26	05/26
NCT05076838: Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy	Active, not recruiting	1/2	30	US	Diazepam Nasal Spray [Valtoco]	Neurelis, Inc.	Epilepsy	08/23	10/24
NCT04903314: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures	Recruiting	1	24	US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	07/24	10/24
Ellis, Michelle
No trials found